Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 14;59(38):16536-16543.
doi: 10.1002/anie.202003788. Epub 2020 Jul 22.

X-Ray Crystallography and Free Energy Calculations Reveal the Binding Mechanism of A2A Adenosine Receptor Antagonists

Affiliations

X-Ray Crystallography and Free Energy Calculations Reveal the Binding Mechanism of A2A Adenosine Receptor Antagonists

Willem Jespers et al. Angew Chem Int Ed Engl. .

Abstract

We present a robust protocol based on iterations of free energy perturbation (FEP) calculations, chemical synthesis, biophysical mapping and X-ray crystallography to reveal the binding mode of an antagonist series to the A2A adenosine receptor (AR). Eight A2A AR binding site mutations from biophysical mapping experiments were initially analyzed with sidechain FEP simulations, performed on alternate binding modes. The results distinctively supported one binding mode, which was subsequently used to design new chromone derivatives. Their affinities for the A2A AR were experimentally determined and investigated through a cycle of ligand-FEP calculations, validating the binding orientation of the different chemical substituents proposed. Subsequent X-ray crystallography of the A2A AR with a low and a high affinity chromone derivative confirmed the predicted binding orientation. The new molecules and structures here reported were driven by free energy calculations, and provide new insights on antagonist binding to the A2A AR, an emerging target in immuno-oncology.

Keywords: G protein-coupled receptor (GPCR); adenosine receptors; biophysical mapping (BPM); free energy perturbation (FEP).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Binding mode and chemical structures of antagonists ZM241385 (A, crystal structure 4EIY26) and triazine 4 b (B). The experimental pose of the triazine (cyan) was superimposed on the same crystal structure of the receptor shown in panel A (ribbons). Both compounds had been characterized by BPM (residues labelled and depicted in gray sticks). Receptor‐ligand hydrogen bonds are depicted as magenta lines.
Figure 2
Figure 2
Putative binding modes A (green) and B (magenta) of Chromone 14 to the A2AAR (H‐bonds in magenta). C) Experimental and calculated changes in binding free energies for each mutation in the BPM. The error bars correspond to the s.e.m. of the replica calculations for the calculated values, or are adjusted to the reported value of 0.1 pK D unit in the case of experimental data.27
Scheme 1
Scheme 1
Structure and synthetic pathways employed to assembly chromones 4, 5 and 8.
Figure 3
Figure 3
A) Dual binding mode of caffeine, as extracted from the A2AAR crystal structure with the A2AAR (PDB code 5MZP). Colour code is green (binding mode A) and magenta (binding mode B). B) modelled binding modes of Chromone 4 a, following the same colouring Scheme as in panel A.
Figure 4
Figure 4
A) Crystal structures of the A2AAR and compound 4 d (PDB code: 6ZDR), ligand shown in sticks and sodium ion shown as a sphere. Electron densities of chromones 4 d (B) and 5 d (C; PDB code: 6ZDV). Omit maps are 2 F oF c at 1 sigma (light blue mesh) and Fo‐Fc at 3 sigma (green mesh). Binding mode of compound 4 d (D) and 5 d (E); ligands and the conserved residue N2536.55 shown as sticks, water molecules in red spheres.
Figure 5
Figure 5
Crystal structure (orange) and modelled coordinates (cyan) of (A) the highest affinity compound 4 d (PDB code: 6ZDR) and (B) the methylated derivative 5 d (PDB code: 6ZDV) with the A2AAR. H‐bond interactions are indicated in magenta.

References

    1. Cournia Z., Allen B., Sherman W., J. Chem. Inf. Model. 2017, 57, 2911–2937. - PubMed
    1. Rao S. N., Singh U. C., Bash P. A., Kollman P. A., Nature 1987, 328, 551–554. - PubMed
    1. Jespers W., Isaksen G. V., Andberg T. A. H., Vasile S., Van Veen A., Åqvist J., Brandsdal B. O., Gutiérrez-De-Terán H., J. Chem. Theory Comput. 2019, 15, 5461–5473. - PubMed
    1. Steinbrecher T. B., Dahlgren M., Cappel D., Lin T., Wang L., Krilov G., Abel R., Friesner R., Sherman W., J. Chem. Inf. Model. 2015, 55, 2411–2420. - PubMed
    1. Gapsys V., Michielssens S., Seeliger D., de Groot B. L., J. Comput. Chem. 2015, 36, 348–354. - PMC - PubMed

Publication types

MeSH terms

Substances